EPS: As of FY2025 Q1, the actual value is USD -0.21.<h3>Segment Revenue</h3><ul><li>The company did not generate any revenue during the three months ended March 31, 2025.</li></ul><h3>Operational Metrics</h3><ul><li>Net Loss: The net loss for the three months ended March 31, 2025 was - $2,017,553, compared to - $1,903,794 for the same period in 2024.</li><li>Operating Expenses: Total operating expenses for the three months ended March 31, 2025 were $2,056,620, compared to $1,965,718 for the same period in 2024.</li><li>Research and Development Expenses: Increased to $576,260 for the three months ended March 31, 2025, from $552,126 for the same period in 2024.</li><li>General and Administrative Expenses: Increased to $1,480,360 for the three months ended March 31, 2025, from $1,413,592 for the same period in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: - $1,798,125 for the three months ended March 31, 2025, compared to - $1,901,634 for the same period in 2024.</li><li>Net Cash Provided by Financing Activities: $164,070 for the three months ended March 31, 2025, compared to $6,287,621 for the same period in 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Accumulated Deficit: As of March 31, 2025, the accumulated deficit was - $18,811,109.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company aims to utilize its bfLEAP™ AI/ML platform to improve drug development processes and enable the success of clinical trials, with plans to acquire rights to drugs at various stages of development and use AI/ML technology to advance them.</li><li>Non-Core Business: The company plans to raise additional capital through sales of equity securities, debt transactions, licensing agreements, and collaborative arrangements to continue executing its strategy.</li><li>Priority: The company has entered into an At-The-Market Sales Agreement with BTIG, LLC, allowing it to offer and sell shares of common stock up to $20 million.</li></ul>

BULLFROG AI HOLDINGS INC C/WTS EXP (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -0.21